On 29 July 2026, the CMU Risk Communication and Awareness Plan for Pharmacovigilance Activities was piloted at the PIMS PMDT site, followed by implementation at the PIMS ART site on 3 August 2026.
The initiative focused on strengthening awareness among healthcare providers and patients regarding pharmacovigilance and the timely reporting of Adverse Drug Reactions (ADRs). The activity aimed to promote patient safety, responsible medicine use, and effective medicine safety practices through improved awareness and reporting.
